TOT BIOPHARM International Company Limited (1875.HK)
HKD 1.65
(0.0%)
HKD 1.65
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | 13.0% |
| 2022 | 1.26 Billion CNY | 77.69% |
| 2021 | 710.26 Million CNY | 10.77% |
| 2020 | 641.18 Million CNY | -36.98% |
| 2019 | 1.01 Billion CNY | 50.22% |
| 2018 | 677.23 Million CNY | 86.03% |
| 2017 | 364.05 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.45 Billion CNY | 0.0% |
| 2023 Q2 | 1.47 Billion CNY | 0.0% |
| 2023 Q4 | 1.42 Billion CNY | 0.0% |
| 2023 FY | 1.42 Billion CNY | 13.0% |
| 2022 FY | 1.26 Billion CNY | 77.69% |
| 2022 Q2 | 812.27 Million CNY | 0.0% |
| 2022 Q4 | 1.41 Billion CNY | 0.0% |
| 2021 Q4 | 710.26 Million CNY | 0.0% |
| 2021 FY | 710.26 Million CNY | 10.77% |
| 2021 Q2 | 633.22 Million CNY | 0.0% |
| 2020 FY | 641.18 Million CNY | -36.98% |
| 2020 Q4 | 641.18 Million CNY | 0.0% |
| 2020 Q2 | 813.93 Million CNY | 0.0% |
| 2019 Q4 | 1.01 Billion CNY | 0.0% |
| 2019 FY | 1.01 Billion CNY | 50.22% |
| 2018 FY | 677.23 Million CNY | 86.03% |
| 2017 FY | 364.05 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -247.836% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 87.321% |